Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 7:30 PM
Ignite Modification Date: 2025-12-25 @ 5:11 PM
NCT ID: NCT01440803
Description: None
Frequency Threshold: 5
Time Frame: Up to 30 months, with the following time points: 1 week, 1 month, 3 month, 6 month, 9 month, 12 month, 18 month, 24 month, 30 month
Study: NCT01440803
Study Brief: Forteo Trial on Idiopathic Osteoporosis in Premenopausal Women
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Placebo Saline Injection (6 Months) Daily injection of saline placebo for 6 months. 0 None 0 13 0 13 View
Teriparatide (Forteo) (24 Months) Daily injection of 20 mcg teriparatide for the treatment of idiopathic osteoporosis for 24 months. 0 None 0 28 0 28 View
Placebo Saline Injection (6-24 Months) Daily injection of 20 mcg teriparatide for the treatment of idiopathic osteoporosis for 18 months following placebo. 0 None 0 13 0 13 View
Serious Events(If Any):
Other Events(If Any):